Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mourmans

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Cardiovascular Diabetology|April 25, 2025
The effect of empagliflozin on peripheral microvascular dysfunction in patients with heart failure with preserved ejection fractionSanne G J Mourmans, Anouk Achten, Raquel Hermans, et al.
Journal of Clinical Medicine|April 13, 2024
Retinal Vascular Changes in Heart Failure with Preserved Ejection Fraction Using <i>Optical Coherence Tomography Angiography</i>Jerremy Weerts, Anne G Raafs, Birgit Sandhoefner, et al.
International Journal of Cardiology. Heart & Vasculature|February 10, 2025
Prevalence and prognostic value of ventricular conduction delay in heart failure with preserved ejection fractionAnouk Achten, Jerremy Weerts, Johan van Koll, et al.
European Journal of Heart Failure|April 6, 2025
Peroxiredoxin-4, a marker of systemic oxidative stress, is associated with incident heart failureNavin Suthahar, Sanne G J Mourmans, Anouk Achten, et al.
European Journal of Heart Failure|May 18, 2026
Intravenous IRON supplementation in Heart Failure with Preserved Ejection Fraction and iron deficiency (IRON-HFpEF): a comprehensive phase II multicentre placebo-controlled randomised clinical trialArno A van de Bovenkamp, Soufiane Nassiri, Frances S de Man, et al.
ESC Heart Failure|July 11, 2025
Immuno-haemostatic dysregulation in heart failure with preserved ejection fractionGiorgia D'Italia, Daniëlle M Coenen, Titus P Lemmens, et al.
European Journal of Heart Failure|May 19, 2025
A simplified approach for diagnosing heart failure with preserved ejection fraction by assessing the left atrium and natriuretic peptidesJerremy Weerts, Arantxa Barandiarán Aizpurua, Ravi B Patel, et al.
American Journal of Physiology. Heart and Circulatory Physiology|August 30, 2024
Relationship between peripheral and intracoronary blood flow in patients with angina and nonobstructive coronary arteriesJanneke Woudstra, Sanne G J Mourmans, Caitlin E M Vink, et al.
ESC Heart Failure|February 4, 2022
Improving diagnosis and risk stratification across the ejection fraction spectrum: the Maastricht Cardiomyopathy registryMichiel T H M Henkens, Jerremy Weerts, Job A J Verdonschot, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Cardiovascular Diabetology|April 25, 2025
The effect of empagliflozin on peripheral microvascular dysfunction in patients with heart failure with preserved ejection fractionSanne G J Mourmans, Anouk Achten, Raquel Hermans, et al.
Journal of Clinical Medicine|April 13, 2024
Retinal Vascular Changes in Heart Failure with Preserved Ejection Fraction Using <i>Optical Coherence Tomography Angiography</i>Jerremy Weerts, Anne G Raafs, Birgit Sandhoefner, et al.
International Journal of Cardiology. Heart & Vasculature|February 10, 2025
Prevalence and prognostic value of ventricular conduction delay in heart failure with preserved ejection fractionAnouk Achten, Jerremy Weerts, Johan van Koll, et al.
European Journal of Heart Failure|April 6, 2025
Peroxiredoxin-4, a marker of systemic oxidative stress, is associated with incident heart failureNavin Suthahar, Sanne G J Mourmans, Anouk Achten, et al.
European Journal of Heart Failure|May 18, 2026
Intravenous IRON supplementation in Heart Failure with Preserved Ejection Fraction and iron deficiency (IRON-HFpEF): a comprehensive phase II multicentre placebo-controlled randomised clinical trialArno A van de Bovenkamp, Soufiane Nassiri, Frances S de Man, et al.
ESC Heart Failure|July 11, 2025
Immuno-haemostatic dysregulation in heart failure with preserved ejection fractionGiorgia D'Italia, Daniëlle M Coenen, Titus P Lemmens, et al.
European Journal of Heart Failure|May 19, 2025
A simplified approach for diagnosing heart failure with preserved ejection fraction by assessing the left atrium and natriuretic peptidesJerremy Weerts, Arantxa Barandiarán Aizpurua, Ravi B Patel, et al.
American Journal of Physiology. Heart and Circulatory Physiology|August 30, 2024
Relationship between peripheral and intracoronary blood flow in patients with angina and nonobstructive coronary arteriesJanneke Woudstra, Sanne G J Mourmans, Caitlin E M Vink, et al.
ESC Heart Failure|February 4, 2022
Improving diagnosis and risk stratification across the ejection fraction spectrum: the Maastricht Cardiomyopathy registryMichiel T H M Henkens, Jerremy Weerts, Job A J Verdonschot, et al.
Pageof 2